The telomeric puzzle in <i>TP53</i> -mutant myeloid neoplasms
In this issue of Blood, Guarnera et al 1 report that telomere content (TC) in specific myeloid neoplasm subgroups (particularly those with complex karyotype and biallelic TP53 mutations) is unexpectedly similar to that in nonmalignant controls, whereas overall myeloid neoplasms generally have lower TC.
Authors
- Lucy C. Fox (ORCID: https://orcid.org/0000-0002-3855-8232)
- Ing Soo Tiong
Institutions
- The University of Melbourne (AU)
- Peter MacCallum Cancer Centre (AU)
Publication Details
- Journal
- Blood
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1182/blood.2025031124
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00